Description: In Veritas Medical Diagnostics, Inc. is engaged in the development of medical devices with near-patient testing applications. The Company is focused on creating point of care devices or systems for the minimally-invasive monitoring of patients. The first product to use the Company’s technology is a prothrombin monitor device, which is used for the measurement of coagulation of blood in patients at risk of heart disease and stroke. The Company operates through its two wholly owned subsidiaries: IVMD (UK) Limited and Jopejo Limited.
The Green House
Inverness,
IV2 3Bl
United Kingdom
Phone:
44 14 6366 7347
Officers
| Name | Title |
|---|---|
| Mr. G. T. Cooper | Chairman, CEO & Pres |
| Mr. Martin E. Thorp | CFO, Principal Accounting Officer & Director |
| Mr. Robert Galvin | Head of Admin. & Financial Controller |
| Prof. Patricia Connolly | Director of Science & Operations |
Exchange: OTCCE
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0.1429 |
| IPO Date: | |
| Fiscal Year End: | July |
| Full Time Employees: | 7 |